Adalimumab/methotrexateVarious toxicities, lack of efficacy and off-label use: 8 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1965卷 / 1期

关键词：

D O I：

10.1007/s40278-023-42991-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：23 / 23

相关论文

共 50 条

[1] Adalimumab/etanercept/methotrexateVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2022, 1889 (1) : 20 - 20
[2] Multiple drugsVarious toxicities, lack of efficacy and off-label use: 8 case reports
Reactions Weekly, 2023, 1982 (1) : 310 - 310
[3] Multiple drugsVarious toxicities, lack of efficacy and off-label use: 8 case reports
Reactions Weekly, 2023, 1984 (1) : 383 - 383
[4] MethotrexateVarious toxicities followed by off-label use: 3 case reports
Reactions Weekly, 2023, 1980 (1) : 244 - 244
[5] Ambrisentan/bosentanVarious toxicities following off-label use and lack of efficacy: 8 case reports
Reactions Weekly, 2021, 1886 (1) : 34 - 34
[6] DalbavancinVarious toxicities, lack of efficacy and off-label use: 7 case reports
Reactions Weekly, 2022, 1925 (1) : 199 - 199
[7] DiflunisalVarious toxicities, lack of efficacy and off-label use: 9 case reports
Reactions Weekly, 2022, 1929 (1) : 254 - 254
[8] AntineoplasticsVarious toxicities, lack of efficacy and off-label use: 4 case reports
Reactions Weekly, 2022, 1903 (1) : 55 - 55
[9] AntineoplasticsVarious toxicities, off-label use and lack of efficacy: 7 case reports
Reactions Weekly, 2022, 1912 (1) : 72 - 72
[10] AntineoplasticsVarious toxicities, lack of efficacy and off-label use: 2 case reports
Reactions Weekly, 2023, 1959 (1) : 91 - 91

← 1 2 3 4 5 →